World Journal of Urology

World Journal of Urology is a monthly journal that Springer publishes, and it carries the essential results of urological research together with their practical and clinical relevance. It began in 1983 and reaches a readership of urologists in research and in practice. Its 2025 impact factor is 3.3.《世界泌尿外科杂志》是 Springer 出版的月刊，刊载泌尿外科研究的核心成果及其临床实用价值。该刊 1983 年创刊，读者覆盖从事研究与临床工作的泌尿外科医师。其 2025 年影响因子为 3.3。

Scope

• The journal conveys the essential results of urological research and presents their practical and clinical relevance to a broad audience of urologists.该刊传递泌尿外科研究的核心成果，并向广泛的泌尿外科医师读者说明其临床与实用价值。

• It sets out to reflect developments in all fields of urology at an internationally advanced level, so that its programme stays balanced.该刊力求以国际先进水平反映泌尿外科各领域的发展，使选题保持均衡。

• Most issues include invited review articles on a chosen topic.多数各期都围绕一个选定主题刊登约稿综述。

• Alongside the themed reviews the journal publishes additional papers on other subjects.在专题综述之外，该刊还刊发其他主题的论文。

• The publisher describes the title as a comprehensive resource for developments in the basic and clinical aspects of urology.出版方把该刊描述为泌尿外科学基础与临床两方面进展的综合资源。

• Its stated readership takes in urologists working in research and in clinical practice.其声明的读者对象包括从事研究的泌尿外科医师与临床执业医师。

• The editorial board is presented as world renowned, and it is credited with keeping peer review swift and rigorous.编委会被描述为享誉世界，并被认为维持了评审的迅速与严格。

• The journal states that it is supported by a world-renowned editorial board that ensures a swift and rigorous peer review process.该刊声明由一个享誉世界的编委会支持，从而保证评审过程迅速而严格。

• Topical collections are opened from time to time, among them one on breakthrough interventions and inventions in endourology.该刊不定期开设专题合集，其中有关于腔内泌尿外科突破性干预与发明的一辑。

• A second collection announced on the journal site concerns single-port robotic surgery in urology, its current evidence and its technical evolution.刊物网站公布的第二个合集讨论泌尿外科的单孔机器人手术，其现有证据与技术演进。

• Publishing follows a hybrid model, so an accepted article may appear behind a subscription or, on payment of an article processing charge, open to all readers.出版采用混合模式，被接收的文章可以放在订阅之后，也可以在支付文章处理费后向所有读者开放。

• The journal reports a median of six days from submission to a first decision and more than a million and a half downloads in 2025.该刊报告投稿至首次决定的中位数为 6 天，2025 年下载量超过 150 万次。

• The editors invite researchers to submit work whose results carry consequences for practice, and the journal states that its programme reflects advances in every field of urology.编辑邀请研究者投递其结果对实践有影响的工作，该刊声明其选题反映泌尿外科各领域的进展。

• Reviews and original papers appear side by side with the themed material, so that a reader meets both synthesis and new data within one volume.综述与原创论文和专题材料并排出现，使读者在同一卷中既能读到综合评述，也能读到新数据。

• The publisher's page invites readers to sign up for journal alerts and to follow the journal's collections and volumes online.出版方的页面请读者订阅刊物提醒，并在线关注该刊的合集与卷次。

History

• The title began in 1983, and its imprint has been Springer throughout.该刊 1983 年创刊，出版方一路都是 Springer。

• It appeared four times a year at the outset, moved to six issues a year in 1994 and has been monthly since 2015.该刊最初每年四期，1994 年改为每年六期，2015 年起按月出版。

• The print edition carries the number 0724-4983 and the electronic edition 1433-8726.印本刊号为 0724-4983，电子刊号为 1433-8726。

• Until 2022 the journal was the official journal of the Urological Research Society.2022 年以前，该刊是泌尿外科研究学会的官方期刊。

• Its record in the National Library of Medicine takes in MEDLINE from volume 11 number 1 in 1993, along with PubMed and Index Medicus.美国国立医学图书馆的编目显示，该刊自 1993 年第 11 卷第 1 期起被 MEDLINE 收录，并列入 PubMed 与 Index Medicus。

• The 2025 impact factor is 3.3, and the five-year figure is also 3.3.该刊 2025 年影响因子为 3.3，五年影响因子同为 3.3。

• The journal reports more than twelve thousand citations and 543 articles in the 2025 snapshot.在 2025 年的快照中，该刊总被引超过 12000 次，年发文 543 篇。

• Its abstracting and indexing list covers agricultural and biological services as well as the medical ones, among them BIOSIS, Biological Abstracts, Chemical Abstracts Service, Medline and the science citation index expanded.其摘录与收录名单既覆盖农业与生物学服务，也覆盖医学服务，其中有 BIOSIS，生物学文摘，化学文摘社，Medline 与科学引文索引扩展版。

• The publisher's page also names Ovid Discovery, ProQuest, EBSCO, Portico and CLOCKSS among the services that carry the journal.出版方的页面还列出 Ovid Discovery，ProQuest，EBSCO，Portico 与 CLOCKSS 等服务承载该刊内容。

• The journal states that it maintains a balanced programme reflecting advances in all fields of urology.该刊表示它维持均衡的选题，反映泌尿外科各领域的进展。

• The title has published continuously since 1983, so its volume numbering reached the forties within the present decade.该刊自 1983 年起连续出版，卷号在本十年内已进入四十年代。

• Its 2025 snapshot records more than twelve thousand citations, 543 articles and a cited half-life of 5.3 years.其 2025 年快照记录总被引超过 12000 次，年发文 543 篇，被引半衰期 5.3 年。

• Thirty per cent of the journal articles were open access in the same snapshot.在同一份快照中，该刊三成文章为开放获取。

• The title appears on the publisher's journal list for surgery and clinical medicine, and manuscripts are handled through the publisher's own system.该刊出现在出版方的外科与临床医学刊物清单中，稿件通过出版方自有的系统处理。

• A pre-submission checklist, submission guidelines and language editing services are provided for authors.出版方为作者提供投稿前检查清单，投稿指南与语言编辑服务。

• Published papers carry digital object identifiers, and the journal takes part in the publisher's agreements with institutions and funders.已发表论文带有数字对象标识符，该刊也参与出版方与机构及资助方达成的协议。

• The journal's volumes and issues, together with its topical collections, can be browsed on the publisher's platform.该刊的卷次，期号以及专题合集都可以在出版方的平台上浏览。

Editors

• (Thomas R.W. Herrmann) of Spital Thurgau in Frauenfeld, Switzerland, is an editor-in-chief.（Thomas R.W. Herrmann）任职于瑞士弗劳恩费尔德的图尔高医院，是该刊主编之一。

• (Alexandre de la Taille) of the Henri Mondor University Hospital in Créteil, France, is the other editor-in-chief.（Alexandre de la Taille）任职于法国克雷泰伊的亨利·蒙多大学医院，是另一位主编。

• (Pierre Bigot) of the University Hospital of Angers in France is an associate editor.（Pierre Bigot）任职于法国昂热大学医院，担任副编辑。

• (Vineet Gauhar) of Ng Teng Fong General Hospital in Singapore is an associate editor.（Vineet Gauhar）任职于新加坡的黄廷方综合医院，担任副编辑。

• (Thomas Knoll) of the Klinikum Sindelfingen-Böblingen in Germany is an associate editor.（Thomas Knoll）任职于德国辛德芬根-伯布林根医院，担任副编辑。

• (Michael S. Leapman) of the Yale School of Medicine in the United States is an associate editor.（Michael S. Leapman）任职于美国耶鲁大学医学院，担任副编辑。

• (Axel S. Merseburger) of the University Hospital Schleswig-Holstein in Kiel is an associate editor, and (Benoit Peyronnet) of the University of Rennes in France is another.（Axel S. Merseburger）任职于基尔的石勒苏益格-荷尔斯泰因大学医院，担任副编辑，（Benoit Peyronnet）任职于法国雷恩大学，也是副编辑。

• (Karim A. Touijer) of the Memorial Sloan Kettering Cancer Center in New York is an associate editor as well.（Karim A. Touijer）任职于纽约的纪念斯隆凯特琳癌症中心，同样是副编辑。

• (Maximilian Pallauf) of the University Hospital of Salzburg and (Abhishek Singh) of the Muljibhai Patel Urological Hospital in India serve as managing editors.（Maximilian Pallauf）任职于萨尔茨堡大学医院，（Abhishek Singh）任职于印度的穆尔吉拜·帕特尔泌尿外科医院，两人担任责任编辑。

• The wider board draws members from the United Kingdom, Sweden, the United States, Argentina, Italy, Switzerland, Germany and Spain, among other countries.更广泛的编委会成员来自英国，瑞典，美国，阿根廷，意大利，瑞士，德国与西班牙等国。

• Members of the board work on topics that include urological oncology, endourology and functional urology.编委的研究方向包括泌尿肿瘤学，腔内泌尿外科与功能泌尿外科。

• Manuscripts are handled by the editors-in-chief together with the associate editors, and the journal reports a median of six days to a first decision.稿件由主编与副编辑共同处理，该刊报告投稿至首次决定的中位数为 6 天。

• The managing editors take care of the day-to-day flow of submissions between the board and the publisher.责任编辑负责编委会与出版方之间日常的稿件流转。

• Between them the editors cover endourology, urological oncology, functional urology and reconstructive surgery.这些编辑的研究覆盖腔内泌尿外科，泌尿肿瘤学，功能泌尿外科与重建外科。

• The board matches the journal's stated aim of combining basic and clinical work, since its members hold posts in university hospitals and in research institutes.编委会与该刊结合基础与临床的既定目标相称，成员任职于大学医院与研究机构。

• Calls for papers are issued for the topical collections, with submission deadlines published on the journal site.该刊为专题合集发布征稿启事，投稿截止日期在刊物网站上公布。